DR. DAVID J. SALINGER, MD

Plain English
This study looked at how well a medication called ustekinumab works for adults with inflammatory bowel diseases, like Crohn's disease and ulcerative colitis. Researchers found that increasing the dose of ustekinumab every four weeks not only improved patients' conditions but also helped prevent the disease from getting worse. Moreover, it's a safer and more cost-effective option for patients who have not responded to other treatments. Who this helps: This research benefits patients with inflammatory bowel diseases, particularly those who need effective treatment options.

Plain English
This study looked at whether people using a digital therapy tool called Woebot could form strong therapeutic relationships similar to those experienced in traditional therapy. The researchers analyzed data from over 36,000 users and found that the level of connection reported by users of Woebot was comparable to that found in face-to-face therapy, with an average bond score of 3.8. This is significant because it shows that digital tools can provide meaningful support for mental health, potentially helping to address the gap in care when there aren't enough mental health professionals available. Who this helps: Patients seeking mental health support, especially in areas with limited access to therapists.

Plain English
This study looked at 107 adult streetworkers in Melbourne, Australia, focusing on how age and drug use affected their emotional well-being and job satisfaction. The findings revealed that older streetworkers who were dependent on drugs felt the most emotionally drained and trapped in their work, which hurt their overall job satisfaction. This is important because it shows that simply enforcing the law won't help these individuals; instead, offering support and finding ways to decriminalize their situation could improve their safety and quality of life. Who this helps: This helps streetworkers who are struggling with addiction and their mental health.

Plain English
This study looked at a new drug called brodalumab to see how safe it is and how well it works for patients with rheumatoid arthritis who didn't respond to the typical treatment methotrexate. Out of the 40 people in the study, 37% who took brodalumab showed some improvement in their symptoms after 13 weeks, compared to 22% who received a placebo, but overall, the drug did not significantly change disease activity. The findings are important because they help determine the potential of brodalumab as a treatment option for difficult-to-treat rheumatoid arthritis patients. Who this helps: Patients with rheumatoid arthritis who have not found relief with standard treatments.

Plain English
This study looked at two ways of giving magnesium sulfate to prevent eclampsia in pregnant women: through a shot in the muscle (IM) and through an IV drip. The researchers found that the IM method led to higher initial levels of magnesium in the blood, but eventually both methods resulted in similar magnesium levels. However, many women still had lower levels of magnesium than needed for effective treatment, suggesting that higher doses may be necessary, especially with the IV method. Who this helps: This research benefits pregnant women at risk of eclampsia by improving treatment approaches.

Plain English
This study looked at ameloblastoma, a type of non-cancerous yet aggressive tumor found in the jaw, and its treatment using radiation therapy. It reviewed past research and discussed a new case, highlighting that this tumor responds well to radiation, which was not fully established before. The article provides specific recommendations on how to use radiation effectively for treating this type of tumor, which can lead to better management of the condition. Who this helps: This benefits patients with ameloblastoma and their doctors by providing improved treatment options.